Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Concomitant Treatment of Malignant Brain Tumours With CBD - A Case Series and Review of the Literature.

Likar R, Koestenberger M, Stultschnig M, Nahler G.

Anticancer Res. 2019 Oct;39(10):5797-5801. doi: 10.21873/anticanres.13783.

PMID:
31570484
2.

Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.

Jeon HJ, Kong DS, Park KB, Lee JI, Park K, Kim JH, Kim ST, Lim DH, Kim WS, Nam DH.

Clin Neurol Neurosurg. 2009 Oct;111(8):679-82. doi: 10.1016/j.clineuro.2009.06.013. Epub 2009 Jul 28.

PMID:
19640635
3.

[Multimodal treatment of glioblastoma multiforme: results of 86 consecutive patients diagnosed in period 2003-2009].

Lakomý R, Fadrus P, Slampa P, Svoboda T, Kren L, Lzicarová E, Belanová R, Siková I, Poprach A, Schneiderová M, Procházková M, Sána J, Slabý O, Smrcka M, Vyzula R, Svoboda M.

Klin Onkol. 2011;24(2):112-20. Czech.

PMID:
21644366
4.

Ten-year review of survival and management of malignant glioma in Hong Kong.

Chan DT, Hsieh SY, Lau CK, Kam MK, Loong HH, Tsang WK, Poon DM, Poon WS.

Hong Kong Med J. 2017 Apr;23(2):134-9. doi: 10.12809/hkmj164879. Epub 2016 Dec 2.

5.

A clinical review of treatment outcomes in glioblastoma multiforme--the validation in a non-trial population of the results of a randomised Phase III clinical trial: has a more radical approach improved survival?

Rock K, McArdle O, Forde P, Dunne M, Fitzpatrick D, O'Neill B, Faul C.

Br J Radiol. 2012 Sep;85(1017):e729-33. doi: 10.1259/bjr/83796755. Epub 2012 Jan 3.

6.

Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme.

Seidlitz A, Siepmann T, Löck S, Juratli T, Baumann M, Krause M.

Radiat Oncol. 2015 Aug 16;10:172. doi: 10.1186/s13014-015-0478-5.

7.

Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.

Birol Sarica F, Tufan K, Cekinmez M, Sen O, Cem Onal H, Mertsoylu H, Topkan E, Pehlivan B, Erdogan B, Nur Altinors M.

J Neurosurg Sci. 2010 Mar;54(1):7-19.

PMID:
20436394
8.

Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide.

Stupp R, Dietrich PY, Ostermann Kraljevic S, Pica A, Maillard I, Maeder P, Meuli R, Janzer R, Pizzolato G, Miralbell R, Porchet F, Regli L, de Tribolet N, Mirimanoff RO, Leyvraz S.

J Clin Oncol. 2002 Mar 1;20(5):1375-82.

PMID:
11870182
9.

[Results of postoperative radiochemotherapy of glioblastoma multiforme].

Lövey J, Fedorcsák I, Bajcsay A, Sipos L, Mangel L, Kásler M, Bagó A.

Magy Onkol. 2013 Dec;57(4):232-9. doi: MagyOnkol.2013.57.4.232. Epub 2013 Nov 1. Hungarian.

10.
11.

The impact of surgery on the efficacy of adjuvant therapy in glioblastoma multiforme.

Brzozowska A, Toruń A, Mazurkiewicz M.

Adv Clin Exp Med. 2015 Mar-Apr;24(2):279-87. doi: 10.17219/acem/40456.

12.

First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience.

Bock HC, Puchner MJ, Lohmann F, Schütze M, Koll S, Ketter R, Buchalla R, Rainov N, Kantelhardt SR, Rohde V, Giese A.

Neurosurg Rev. 2010 Oct;33(4):441-9. doi: 10.1007/s10143-010-0280-7. Epub 2010 Aug 13.

13.

Concomitant and adjuvant temozolomide of newly diagnosed glioblastoma in elderly patients.

Behm T, Horowski A, Schneider S, Bock HC, Mielke D, Rohde V, Stockhammer F.

Clin Neurol Neurosurg. 2013 Oct;115(10):2142-6. doi: 10.1016/j.clineuro.2013.08.002. Epub 2013 Aug 12.

PMID:
23993314
14.

Therapy for patients with high grade astrocytoma using intraarterial chemotherapy and radiation therapy.

Madajewicz S, Chowhan N, Tfayli A, Roque C, Meek A, Davis R, Wolf W, Cabahug C, Roche P, Manzione J, Iliya A, Shady M, Hentschel P, Atkins H, Braun A.

Cancer. 2000 May 15;88(10):2350-6.

PMID:
10820358
15.

Toxicity and survival in primary glioblastoma patients treated with concomitant plus adjuvant temozolomide versus adjuvant temozolomide: results of a single-institution, retrospective, matched-pair analysis.

Gutenberg A, Bock HC, Reifenberger G, Brück W, Giese A.

Acta Neurochir (Wien). 2013 Mar;155(3):429-35. doi: 10.1007/s00701-012-1583-y. Epub 2012 Dec 20.

PMID:
23254891
16.

The impact of sequential vs. combined radiochemotherapy with temozolomide, resection and MGMT promoter hypermethylation on survival of patients with primary glioblastoma--a single centre retrospective study.

Rapp M, Goeppert M, Felsberg J, Steiger HJ, Sabel M.

Br J Neurosurg. 2013 Aug;27(4):430-5. doi: 10.3109/02688697.2013.767317. Epub 2013 Feb 18.

PMID:
23418781
17.

Validation of the Effectiveness and Safety of Temozolomide during and after Radiotherapy for Newly Diagnosed Glioblastomas: 10-year Experience of a Single Institution.

Joo JD, Kim H, Kim YH, Han JH, Kim CY.

J Korean Med Sci. 2015 Nov;30(11):1597-603. doi: 10.3346/jkms.2015.30.11.1597. Epub 2015 Oct 16.

18.

Analysis of Treatment Tolerance and Factors Associated with Overall Survival in Elderly Patients with Glioblastoma.

Zhang C, Wang X, Hao S, Su Z, Zhang P, Li Y, Song G, Yu L, Wang J, Ji N, Xie J, Gao Z.

World Neurosurg. 2016 Nov;95:77-84. doi: 10.1016/j.wneu.2016.07.079. Epub 2016 Jul 30.

PMID:
27485530
19.

Association of patterns of care, prognostic factors, and use of radiotherapy-temozolomide therapy with survival in patients with newly diagnosed glioblastoma: a French national population-based study.

Fabbro-Peray P, Zouaoui S, Darlix A, Fabbro M, Pallud J, Rigau V, Mathieu-Daude H, Bessaoud F, Bauchet F, Riondel A, Sorbets E, Charissoux M, Amelot A, Mandonnet E, Figarella-Branger D, Duffau H, Tretarre B, Taillandier L, Bauchet L.

J Neurooncol. 2019 Mar;142(1):91-101. doi: 10.1007/s11060-018-03065-z. Epub 2018 Dec 6.

20.

Patterns of care and survival for patients with glioblastoma multiforme diagnosed during 2006.

Yabroff KR, Harlan L, Zeruto C, Abrams J, Mann B.

Neuro Oncol. 2012 Mar;14(3):351-9. doi: 10.1093/neuonc/nor218. Epub 2012 Jan 12.

Supplemental Content

Support Center